Pfizer is planning to supply 4 million Covid antiviral treatments

Pfizer is planning to supply 4 million Covid antiviral treatments

March 23, 2022: -Pfizer is about to supply up to 4 million courses of its oral Covid-19 antiviral treatment to dozens of poorer nations with the help of the United Nations Children’s Fund, the company announced Tuesday.

According to the company, Pfizer expects to start supplying the antiviral pills, Paxlovid to UNICEF beginning from the coming month and will continue to do so through the end of the year. According to Pfizer, low-income nations will receive the medications at a not-for-profit price, while upper-middle-income countries will pay more under a tiered pricing system.

Pfizer has licensed Paxlovid through the Medicines Patent Pool, a U.N.-backed public health organization, allowing other companies to produce a generic, low-cost version of the Covid treatment to boost supply in lower-income nations throughout the world. So far, 35 companies in 12 countries across Latin America, the Middle East, and South and East Asia have signed agreements to produce the raw ingredients or the finished drug.

The agreement with UNICEF will supply Paxlovid to the 95 low- and middle-income nations targeted by the licensing agreement. According to Pfizer, the goal is to provide short-term access to oral antiviral treatment as companies get the generic manufacturing up and running.

The U.S. Food and Drug Administration authorized Paxlovid on an emergency basis in December for people 12 years of age and older. Paxlovid was 89% effective at preventing hospitalization in those at high risk of Covid in clinical trials.

Pfizer is expecting $22 billion in sales for Paxlovid in 2022 based on deals already signed or close to finalization. The drugmaker is agreeing to supply 20 million courses of Paxlovid to the U.S. government through September of this year.

Paxlovid is administered very soon after a Covid-19 diagnosis in a three tablet course twice daily for five days. Patients take two nirmatrelvir pills, developed by Pfizer, with one tablet of ritonavir, a widely used HIV drug. Nirmatrelvir inhibits an enzyme the virus needs to replicate, while ritonavir works to slow the patients’ metabolism to permit the drug to remain active in the body for a longer period of time.

While Pfizer is licensing Paxlovid for generic manufacturing, the drugmaker has not done the same for its Covid vaccine. Oxfam America has called on shareholders at the company’s annual meeting to support a feasibility study on transferring the technology underlying the vaccine to developing nations.

Pfizer’s board is calling on shareholders to vote against the proposal, contending that the technology underlying the vaccine is complex and requires a high-level proficiency to maintain the quality of the shots. Pfizer is also aiming to supply 2 billion vaccine doses to poorer nations by 2022.

About Us

We provide the insights on leaders who are responsible for taking their organization to new heights, all the while bringing together a group of talented individuals.

Recent Posts

Tristar Coatings | Transforming The Painting Industry With Innovation | Svetlana Melkova

There are many challenges facing the painting and coating industry today, and the pandemic just added fuel to the fire. These include raw material shortages and the globalization of the painting and coating market. Other challenges include increasing regulations due to environmental concerns and increasing manufacturing costs and raw materials. Ontario-based Tristar Coatings has been able to leverage its extensive knowledge base and highly skilled chemists to provide the solutions today’s organizations need in the time they require it most. In overarching terms, customer performance requirements can mean increasing product output whilst streamlining the process in which that product is manufactured. This can come in the form of preparing the substrate before the painting process (whether that be with physical or chemical cleaning) or actual product modifications to prevent or promote certain properties in the coating (such as adhesion, corrosion protection, film build, UV resistance, etc.), but Tristar has it all.

The Lake Companies | Making Manufacturing Easier…Forever! | Greg Lake

The Lake Companies knows that to achieve best practices, specific daily business processes must happen and be done as simply as possible, even without human effort. “That’s how we develop our ERP software products. We strive to completely transform internal business processes and revolutionize the user experience with our software,” says Greg Lake, President of The Lake Companies. “Building the support for best practices in our software allows our customers to achieve far more than they anticipated, while paving the way for growth into advanced IoT and Industry 4.0 technologies. Our Simple, Elegant, and Powerful solutions are built specifically for and seamlessly integrate with Infor’s SyteLine®(CloudSuite®) ERP.”

Cyncly | Preparing Customers for the Future | Andrea Gnoato

Cyncly was created in September of 2022 as the new brand to unite Compusoft, 2020, and their affiliate companies after the two companies merged in 2021. One of the key factors driving the decision to form Cyncly as a global brand was that consumers worldwide wanted a seamless experience when they decided to improve their homes. And because Cyncly had brought together all these industry-leading software solutions – retailers, designers, and manufacturers in kitchens, bathrooms, furniture, windows, and doors – they were in a unique position to provide their customers with the tools to do this. By connecting all these previous disparate elements, they were able to help companies using our software make their consumers’ journeys seamless and put consumers at the heart of what they do.

ArtiFlex Manufacturing | A Leader In Engineered Solutions | Erin Hoffmann

ArtiFlex Manufacturing is a premier resource for design, tooling, prototyping, automation, past model service, factory assist, and low volume tooling/production solutions. The team consists of passionate high-performance people organized in a lean fashion. The company partners with their customers to implement innovative tooling and manufacturing solutions while managing their complex programs.

Tecnomatix | Making Transformative Products | Tony Hemmelgarn

Tecnomatix® is a comprehensive portfolio of digital manufacturing solutions that helps companies to digitalize manufacturing and the process of turning innovative ideas and raw materials into transformative products. It is a software suite that enables organizations to create a digital twin of their manufacturing processes, including robots, automation, material handling systems, and people, to improve the performance of their business. The software is used in various industries such as electronics, automotive, aerospace, and heavy equipment and is currently owned by Siemens AG.

Pfizer is planning to supply 4 million Covid antiviral treatments